Measurement of CSF α‐synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer’s disease

Clicks: 173
ID: 274280
2019
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
sáez‐valero2019journalmeasurement Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors María‐Salud García‐Ayllón,José‐Antonio Monge‐Argilés,Victoria Monge‐García,Francisco Navarrete,Maria‐Angeles Cortés‐Gómez,José Sánchez‐Payá,Jorge Manzanares,Ruth Gasparini‐Berenguer,Carlos Leiva‐Santana,Javier Sáez‐Valero;María‐Salud García‐Ayllón;José‐Antonio Monge‐Argilés;Victoria Monge‐García;Francisco Navarrete;Maria‐Angeles Cortés‐Gómez;José Sánchez‐Payá;Jorge Manzanares;Ruth Gasparini‐Berenguer;Carlos Leiva‐Santana;Javier Sáez‐Valero;
Journal Journal of Neurochemistry
Year 2019
DOI
10.1111/jnc.14719
URL
https://sciprofiles.com/publication/view/d4eeaefad360cc0f99afa6e54fbba4af
Keywords
mild cognitive impairment Biomarker diagnosis alzheimer lewy body disease α‐synuclein

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.